Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    • Cancer
    • Lung Cancer
    • Non-Small Cell Lung Cancer (NSCLC)